Literature DB >> 32642291

Outcome patterns of cervical adenocarcinoma and squamous cell carcinoma following curative surgery: before and after propensity score matching analysis of a cohort study.

Jiaqiang Zhang1, Lei Qin2, Ho-Min Chen3, Han-Chuan Hsu4, Chih-Chi Chuang4, Dar Chen4, Szu-Yuan Wu3,5,6,7,8.   

Abstract

To estimate the outcome patterns and predictors of curative surgery for cervical squamous cell carcinoma (SCC) and adenocarcinoma (ADC) for overall survival (OS), locoregional recurrence (LRR), and distant metastasis (DM), we enrolled 4628 patients who had received a diagnosis of cervical SCC or ADC and received curative surgery. Cox regression analysis was employed to calculate hazard ratios and confidence intervals (CIs); independent predictors were controlled for or stratified in the analysis, and the endpoint was all-cause death. Propensity score matching was conducted to create well-balanced groups. Multivariate Cox regression analysis indicated that the pathologic type of ADC, age ≥ 70 years, advanced pathologic stage, positive margin, poorly differentiated cancer, undifferentiated cancer, adjuvant sequential chemotherapy and radiotherapy, earlier year of diagnosis, Charlson comorbidity index (CCI) = 1, CCI ≥ 2, low income levels, and treatment at a nonmedical center were significant independent poor prognostic factors for all-cause mortality in cervical cancer treated with curative surgery. Adjusted hazard ratios (95% CIs) for patients with cervical ADC who received curative surgery were 2.34 (1.96-2.79), 1.15 (0.89-1.49), and 2.16 (1.75-2.66) compared with cervical SCC for all-cause mortality, LRR, and DM, respectively. This study indicated that curative surgery for cervical ADC was associated with poorer OS and higher DM rates relative to cervical SCC, but no significant differences were identified in LRR. AJCR
Copyright © 2020.

Entities:  

Keywords:  Surgery; cervical adenocarcinoma; cervical squamous cell carcinoma; locoregional recurrence; metastasis; survival

Year:  2020        PMID: 32642291      PMCID: PMC7339276     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  3 in total

1.  Insufficient pain control for patients with cancer and dementia during terminal cancer stages.

Authors:  Wei-Hung Hsu; Jyh-Gang Hsieh; Ying-Wei Wang; Chia-Jung Hsieh; Huang-Ren Lin; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

2.  Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity.

Authors:  Jiaqiang Zhang; Chang-Yun Lu; Ho-Min Chen; Szu-Yuan Wu
Journal:  JAMA Netw Open       Date:  2021-03-01

3.  Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical Cancer.

Authors:  Renata A M Rossetti; Ildefonso A da Silva-Junior; Gretel R Rodríguez; Karla L F Alvarez; Simone C Stone; Marcella Cipelli; Caio R F Silveira; Mariana Carmezim Beldi; Giana R Mota; Paulo F R Margarido; Edmund C Baracat; Miyuki Uno; Luisa L Villa; Jesus P Carvalho; Kaori Yokochi; Maria Beatriz S F Rosa; Noely P Lorenzi; Ana Paula Lepique
Journal:  Front Oncol       Date:  2020-11-19       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.